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Abstract
Background Chronic pain (CP) is an important public health problem be-
cause of its high prevalence and its effects on the physical and psychological
well-being of individuals. The association between CP and physical activity
(PA) has been discussed in previous literature. However, in most studies, the
assessments of PA is done via self report, which can be affected by substantial
bias and measurement error. In recent years, the use of wearable technology
allowed the objective quantification of the frequency, duration, and intensity of
PA. The current study is focused on assessing the associations between objec-
tively measured PA chronic upper limb pain, chronic spinal pain, and chronic
lower limb pain in U.S. adults.
Methods The sample was comprised of U.S. adults aged between 25 and 85
years from the 2003-2004 National Health and Nutritional Examination Survey
data (NHANES, N = 2, 516), and was stratified into age- and gender-specific
groups. PA data obtained via hip-worn accelerometry were summarized into
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6 objective measures of volume and 2 measures of fragmentation. Survey-
weighted regression models were conducted which regressed each PA measure
on location-specific pain indicator, with and without adjustment for potential
confounders, including age, race/ethnicity, behaviors, and medical conditions.
Results Chronic upper limb pain, chronic spinal pain, and chronic lower limb
pain showed higher prevalence among females and middle-aged study partic-
ipants. All three types of CP were strongly associated with lower levels of
physical activity in 45-65 years old females. Males aged 25-45 or 65-85 years old
with either CP in spine or leg also engaged in less physical activity than those
without pain. The statistical significance of the associations remained, even
after adjusting for relevant covariates.
Conclusion This study identified statistically significant associations between
objectively measured PA and self-reported CP. The magnitude of the signal
varies with the reported location of CP, gender, and age category. These find-
ings may inform that clinical management could be targeted by the CP loca-
tion. Moreover, results emphasized the importance of wearable technology for
providing objective and reproducible measurements in health-related research.
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iii
Acknowledgments
First and foremost, I would like to express my deepest gratitude to my advi-
sor, Professor Ciprian Crainiceanu for his invaluable supervision, continuous
support, motivation, and patience during my graduate study.
I also wish to express my sincere thanks to Professor Jiawei Bai, who is the
second reader of this thesis and provides insightful comments and suggestions.
I would like to extend my appreciation to Dr. Andrew Leroux. He has provided
me assistance at every stage of this research project.
In addition, I hope to thank everyone in the Wearable and Implantable Tech-
nology Research Group. Their immense knowledge and plentiful experience
sharpen my thinking and bring my work to a higher level.
Last, I wish to offer my special thanks to my family and friends for their un-





List of Tables viii
List of Figures ix
1 Introduction 1
1.1 Background of Chronic Pain . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Definition & Impacts . . . . . . . . . . . . . . . . . . . . . . 1
1.1.2 Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . 3




2.1 Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.1.1 NHANES Datasets . . . . . . . . . . . . . . . . . . . . . . . 7
2.1.2 Pain Classification . . . . . . . . . . . . . . . . . . . . . . . 9
2.1.3 Study Population . . . . . . . . . . . . . . . . . . . . . . . . 10
2.2 Variables and Measures . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2.1 Accelerometer-assessed Physical Activity Variables . . . . 11
2.2.2 Confounding Variables . . . . . . . . . . . . . . . . . . . . . 13
2.3 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.3.1 Exploratory Analysis . . . . . . . . . . . . . . . . . . . . . . 15
2.3.2 Statistical Models . . . . . . . . . . . . . . . . . . . . . . . . 16
3 Results 19
3.1 Exploratory Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 19
3.1.1 Prevalence of Chronic Pain . . . . . . . . . . . . . . . . . . 19
3.1.2 Demographic and Clinical Characteristics . . . . . . . . . . 21
3.1.3 PA Characteristics . . . . . . . . . . . . . . . . . . . . . . . 23
3.2 Non-stratified Models for Association between PA and Pain Status 27
3.3 Stratified Models for Association between PA and Pain Status . . 30
3.3.1 Associations in the entire age group . . . . . . . . . . . . . 30
vi
CONTENTS
3.3.2 Associations in the 25-45 years old age group . . . . . . . . 33
3.3.3 Associations in the 45-65 years old age group . . . . . . . . 36
3.3.4 Associations in the 65-85 years old age group . . . . . . . . 39
4 Discussion 42
A R Code for Model Fitting 46
A.1 Non-stratified Models . . . . . . . . . . . . . . . . . . . . . . . . . . 46




3.1 Summaries of demographic and medical characteristics, organized
by location-specific CP groups, CP in any location group, and no
pain group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.2 Associations of PA and location-specific chronic pain for the whole
age group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.3 Associations of PA and location-specific chronic pain for the whole
age group stratified by gender . . . . . . . . . . . . . . . . . . . . . 31
3.4 Associations of PA and location-specific chronic pain for the 25-45
age group stratified by gender . . . . . . . . . . . . . . . . . . . . . 34
3.5 Associations of PA and location-specific chronic pain for the 45-65
age group stratified by gender . . . . . . . . . . . . . . . . . . . . . 37
3.6 Associations of PA and location-specific chronic pain for the 65-85
age group stratified by gender . . . . . . . . . . . . . . . . . . . . . 39
viii
List of Figures
3.1 Number of people reporting chronic pain at various body loca-
tions stratified by gender and age . . . . . . . . . . . . . . . . . . . 20
3.2 Average daily value of eight PA measures as functions of age
stratified by gender and pain locations . . . . . . . . . . . . . . . . 23
3.3 Average daily pattern of minute-level PA for the entire age group
stratified by gender and pain locations . . . . . . . . . . . . . . . . 25
3.4 Average daily pattern of minute-level PA group for different age




1.1 Background of Chronic Pain
1.1.1 Definition & Impacts
Chronic pain (CP) is a highly prevalent health problem that is associated with
high costs for the individual and the health system. According to the Inter-
national Association for the Study of Pain (IASP), CP is defined as pain that
persists beyond the normal tissue healing time [1]. Even after the illness or
injury that caused pain has gone, the pain signals can still be sent and per-
ceived for a prolonged period of time. Chronic pain is not always attributed
to a specific cause; some people report it even if they have not suffered an in-
jury or apparent body damage. Although it has become a health crisis due
to its high prevalence, there is no universally accepted standard definition for
1
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chronic pain. A common definition identifies chronic pain as pain lasting for at
least three months. Other definitions include information about pain frequency
and intensity [2,3].
CP may be linked to conditions occurring in different painful regions. In the
IASP criteria, CP has been categorized according to the body location: (i) head,
face, and mouth; (ii) cervical region; (iii) upper shoulder and upper limbs; (iv)
thoracic region; (v) abdominal region; (vi) lower back, lumbar spine, sacrum,
and coccyx; (vii) lower limbs; (viii) pelvic region; and (ix) anal, perineal, and
genital region [4]. In an internet-based survey studying the prevalence of
chronic pain in the U.S. adults, the most common locations for CP were lower
back, knee, neck, shoulder, and legs or feet [2].
CP is currently a major public health issue. The estimates of chronic pain
prevalence vary from 10.1% to 55.2% according to 13 studies conducted in var-
ious countries including the U.K., Australia, Canada, and France [5]. Hetero-
geneity in these findings might be caused by factors including study samples,
survey methodology, and CP definition [2]. In a multi-center study carried out
in 1998 by the World Health Organization (WHO), chronic pain affected 22% of
the world population [6]. In the U.S., from a study analyzing National Health
Interview Survey data, an estimated 20.4% of U.S. adults (≈ 50.0 million) had
chronic pain and 8.0% of adults (19.6 million) had high-impact chronic pain that
limited at least one major life activity in 2016 [7].
CP may contribute to functional impairment, disability, depression and anxi-
ety, and it is often difficult to treat [8]. Recently, lumbar and cervical pain has
been identified as one of the 10 leading causes of incapacity worldwide [6]. In
the U.S., 13% of the people who suffered pain in previous 2 weeks reported a
reduced ability to work. Approximately 61 billion dollars of lost productivity
2
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each year is estimated to be associated with CP [8].
In addition to the effects on the individual, CP increases the economic burden
on health care services around the world. It has been reported that CP is as-
sociated with a two-fold increase in medical consultations and hospitalizations
and five times higher utilization of emergency services. The estimated cost for
CP in the United States is ranging from $560 to $635 billion annually [9]. In
summary, CP has become a severe public health problem due to its effects on
the individual well-being and health care services.
1.1.2 Risk Factors
Although the prevalence estimates of chronic pain differ in epidemiologic stud-
ies, the potential factors related to CP have been generally consistent [2]. For
example, there is a higher prevalence of CP among females and the elderly pop-
ulation [10]. A two-fold increase has been reported in the odds of incidence of
pain among the age group older than 75 years compared to the group between
18 and 25 years, which might be attributed to the aging of musculoskeletal sys-
tem aging [6]. Moreover, non-Hispanic white adults have a higher prevalence
of reported CP [7].
Furthermore, indicators of lower socioeconomic status, including lower educa-
tion level, manual occupations, unemployment, and residence in public hous-
ing, are associated with an increased prevalence of CP [2]. CP is less prevalent
among adults with a bachelor’s degree or higher compared to all other edu-
cation levels. A recent study showed that, among unemployed individuals the
prevalence of CP was 78.9% compared to 39.8% among individuals with paid em-
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ployment [11]. In addition cigarette use, alcohol use, marriage status, veteran
identity, body mass index (BMI), mental health, genetics, and some medical
conditions also have a close association with CP [10].
1.2 Chronic Pain and Physical Activity
In this section we focus on the association between CP and physical activity
(PA). It is well known that regular physical activity is closely related to the im-
provement and maintenance of health [12, 13]. Several large population stud-
ies have shown that individuals with CP have lower levels of PA than healthy
controls, and those who are more physically active have a lower risk of devel-
oping CP and reduce ongoing pain symptoms. For example, a 14-year prospec-
tive longitudinal study investigated whether exercise was associated with a
substantial reduction in musculoskeletal pain after controlling for gender and
BMI [14]. The epidemiological research from the Nord-Trondelag Health Study
(HUNT 3) identified a linear association between CP and the frequency, dura-
tion, and intensity of recreational exercise for the older individuals. It found
that the prevalence of CP was 21% to 38% lower among older women who have
higher levels of physical activity [15]. Another cross-sectional study found a
U-shaped relationship between PA and lower back pain (LBP), concluding that
both the extremes of low and high PA levels are associated with a high risk of
LBP [16].
PA and CP could be connected bidirectionally, although the direction of causal-
ity has not yet been inferred. Some evidence supports the idea that individuals
with pain may reduce their activity and PA reduces CP by counteracting the
4
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decline in pain modulatory capacity [17]. Several studies have focused on the
association between PA and CP, especially on how PA is associated with chronic
widespread pain (CWP). CWP is defined by the American College of Rheuma-
tology (ACR) as the pain in the left and right sides of the body, above and below
the waistline, together with axial skeletal pain [18]. A study showed that in-
dividuals with CWP tended to have lower activity counts per minute and less
time spent in moderate-to-vigorous PA than people without CWP. However,
sedentary behavior, light, and lifestyle PA were not found to be associated with
CWP status [19]. The study also identified gender differences in the prevalence
of CWP and PA among U.S. adults [20]. Our research focus is CP in several
specific body sites, including chronic spinal pain, which is the biggest cause of
years of life with disability worldwide [21]. Our overall goal is to examine the
association between location-specific CP and PA.
An important aspect of our analysis is to use the objectively measure PA data.
Most traditional investigations characterizing PA in adults with CP were based
on questionnaires and surveys. However, self-reported assessments of PA are
highly subjective and imprecise, leading to potential measurement errors as
well as substantial recall, cognitive and social desirability bias [22–24]. Partic-
ipants may also have different perceptions of PA intensity, timing, and volume
and their answers can be affected by cognitive impairment, which is related
to their health status, age, mood, and psychosocial factors [25]. Wearable de-
vices that include accelerometers provide detailed, objective measurements of
daily PA which can complement the self-reported PA. Accelerometers typically
measure the acceleration of a particular part of the body (e.g., thigh, hip, wrist)
in three orthogonal axes and is measured in m/s2. The raw data are typi-
cally summarized at the minute level using proprietary algorithms (e.g., activ-
ity counts) or open source algorithms (e.g., Euclidian Norm Minus One [26],
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Activity Index [27, 28], Mean Amplitude Deviation [29]). The advantage of
accelerometers is that they can be used to track continuous activities of daily
living at high resolution, and then provide the duration, intensity, and patterns
of PA data within and across days [30].
As the associations between self-reported and objective measures of PA tend to
be weak in general and weaker within populations with CP [25,31], character-
izing PA with accelerometers becomes an exciting alternative to subjectively
measured PA. Unfortunately, there is a very limited literature on the associ-
ation between CP and objectively measured PA. To address this problem, we
focus on the National Health and Nutrition Examination Survey (NHANES),
which contains measures of free-living PA behaviors using hip-worn accelerom-
eters in a population-based sample in the US. We will focus on quantifying and
comparing PA intensity, volume and patterns among adults with or without CP






The National Health and Nutrition Examination Survey (NHANES) is a na-
tionally representative, cross-sectional survey conducted by the Centers for
Disease Control (CDC) to provide information on the health and nutritional
status of the U.S. population. It began in the early 1960s and became contin-
uously implemented since 1999 [32]. It combines interviews collecting person-
level demographic, health-related, and socioeconomic information, combined
with medical, dental, and physiological examinations as well as clinical labo-
ratory tests [33]. Therefore, “NHANES data could help monitor trends in the
prevalence, awareness, treatment, and control of specific diseases and provide
7
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information for medical and public health studies” [34].
NHANES datasets are released in 2-year cycles [33]. Our analysis uses the
NHANES 2003-2004 dataset, which sampled the noninstitutionalized civilian
population living in the 50 United States and the District of Columbia. In
the sampling procedure, NHANES conducts a stratified, multistage probability
sampling design, which over-samples the certain groups, such as African Amer-
icans, Mexican Americans, low-income persons, and those aged 12-19 years and
60 years or older [35]. The NHANES 2003-2004 survey contains data for 10, 122
individuals of all ages, and standardized data-collection methods have been
used to minimize site-specific error and inter-examiner bias [34,36].
In the 2003-2004 cycle, NHANES added a PA monitor (PAM), which was used to
collect objective information on PA for the U.S. population. All ambulatory par-
ticipants aged 6 years and over were asked to wear PAMs on the right hip for 7
consecutive days except during sleeping, swimming, or bathing. The PAM used
in NHANES was the uniaxial ActiGraph AM-7164 accelerometer (ActiGraph,
Ft. Walton Beach, FL), which could summarize acceleration data as activity
counts over each 1-minute time interval [37]. In the following analysis, we use
this dataset to assess the intensity and duration of PA.
For the purpose of our analysis, we are also interested in the following NHANES
datasets to derive the traditional risk factors of chronic pain: (i) “Sample per-
son demographics” file, which includes demographic variables such as gender,
age, race/ethnicity, and education status; (ii) “Clinical laboratory testing” files,
which provide information on body measurements, including the body mass
index (BMI); and (iii) “Medical condition” file, which provides self-reported his-
tory of cancer, stroke, congestive heart failure, diabetes, etc.; (iv) Question-
naire files, which provide information on current employment, alcohol con-
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sumption, and cigarette/tobacco use information. These NHANES datasets
are all publicly available from the CDC website at https://www.cdc.gov/
nchs/nhanes/index.htm.
2.1.2 Pain Classification
CP was defined based on individual’s responses to the “Miscellaneous pain”
questionnaire collected during the household interview. Study participants re-
ported whether they had a problem with pain that lasted more than 24 hours
during the past month. Study participants who answered “no” were identified
as part of the no pain group. Study participants who answered “yes”, were
further asked for how long they have experienced the pain. According to the
American College of Rheumatology (ACR) criteria [18], individuals reporting
pain for more than 3 months were identified as part of the chronic pain group,
and those with pain for less than 3 months were identified as part of the acute
pain group. Based on this definition and the NHANES data, we have created a
three level variable to indicating no pain, chronic pain, and acute pain. As the
focus of this document is primarily on current, chronic, non-minor pain, indi-
viduals who report acute pain at the time of examination are excluded from all
analyses.
Additionally, the NHANES questionnaire also asked about the pain status on
32 body regions (such as right/left shoulder, right/left elbow, head, low back,
etc.), which are shown on a pictorial manikin displaying the front and back
of a human figure. Participants with CP need to indicate whether they are
experiencing pain at each potential pain location. Considering the practical
value for clinical applications and the requirement of a large enough sample
9
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size, in this study, we analyze the following three specific pain locations: (i)
pain in upper limbs (shoulder/girdle, upper arm, mid-arm, lower arm, hand);
(ii) spinal pain (upper back, lower back, neck, spine); and (iii) pain in the lower
limbs (buttock, upper leg, mid-leg, lower leg, foot). The three location-specific
pain indicators were coded as binary variables (presence/absence) [19,38].
2.1.3 Study Population
The NHANES 2003-2004 accelerometry data were downloaded, processed, and
combined with demography, clinical laboratory tests, miscellaneous pain, and
employment variables as well as survey weights [39]. For the purpose of our
analysis, we limit our sample population to the participants aged 25 to 85 years
old in the no pain group or chronic pain group. The sample size for these data
is 3, 347. For accelerometry, we define a “valid day” as a day when accelerome-
try data were collected for a minimum of 10 hours. Study participants who had
fewer than three valid days were excluded from the analysis (N = 544). Ad-
ditional study participants were excluded for having missing covariates: body
mass index (BMI) (N = 29); education status (N = 3); alcohol consumption in-
formation (N = 181); cigarette/tobacco use (N = 1); diabetes mellitus (N = 47);
congestive heart failure (CHF) (N = 11); asthma (N = 6); emphysema (N = 3);
bronchitis (N = 6); cancer (N = 6); myocardial infarction (N = 6); and stroke
(N = 3). The final data set includes 2, 516 individuals, among which 1, 263
are females and 1, 253 are males. Among the 2, 516 study participants, 2, 060
reported no pain, and 407 reported chronic pain in at least one body location
(upper limbs, spine, or lower limbs). Among the ones suffering chronic pain,




In this analysis, we compare PA summaries between individuals who report
location-specific chronic pain and individuals who report neither chronic nor
acute pain at the time of examination. As a result, individuals may be repre-
sented in multiple chronic pain groups if they have chronic pain in more than
one location, however the no pain group is consistent across all comparisons.
2.2 Variables and Measures
2.2.1 Accelerometer-assessed Physical Activity
Variables
Physical activity measurements are assessed objectively using an accelerome-
ter (Actigraph AM-7164), which produced data expressed as activity counts in
1-minute epochs, where more intense activity is associated with higher activity
counts. Because such minute-level accelerometer-derived PA data are large, it
is common to transform the raw activity counts to a number of indicators of PA.
In this analysis, we derive the following PA measurements to capture different
aspects of an individual’s physical activity profile:
Measures of PA volume:
a) Total activity counts (TAC): the sum of all activity counts accumulated on




b) Total log-transformed activity counts (TLAC), or total log (1 + activity
count): similar to TAC but reduces the strong right skewness of the TAC.
TLAC is calculated by transforming minute-level activity count to log (1
+ activity count) and then adding over all minutes of the day.
c) Mean activity counts per minute (CPM): calculated via dividing TAC for
a valid day by the number of minutes of wear time.
d) Sedentary activity (ST): the total number of minutes during the day when
the individual was sedentary, where a sedentary minute is defined as
having an activity count < 100. ST contains sitting or lying down while
awake, and it is characterized by an energy expenditure < 1.5 metabolic
equivalents (METs). 1 MET is defined as the energy expenditure when
resting.
e) Light-intensity physical activity (LIPA): defined as the number of minutes
during the valid wear day with an activity count ≥ 100 and < 2, 020, and
it could be considered as the combination of light activity and lifestyle
activity. Its energy expenditure of LIPA ≥ 1.5 METs and < 3.0 METs.
f) Moderate-to-vigorous activity (MVPA): defined as the number of minutes
during the valid wear day with an activity count ≥ 2, 020. It is a com-
bination of moderate-intensity PA (2, 020 - 5, 998 counts per minute) and
vigorous-intensity PA (≥ 5, 999 counts per minute), and includes fast walk-
ing, jogging, bicycling uphill. The energy expenditure of MVPA ≥ 3.0
METs. [40,41]
Measures of PA fragmentation:
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a) Active to sedentary transition probability (ASTPsl/nw): denotes the proba-
bility of transitioning from an active to a sedentary state. It is calculated
as the reciprocal of the average active bout duration, where the active
bout length is defined as the number of consecutive minutes spent in an
active state (activity counts ≥ 100 counts per minute). Since functional
decline is usually characterized by the progressive shortening of the ac-
tive bout duration, ASTP is highly related to clinical measures of physical
function in adults [42].
b) Sedentary to active transition probability (SATPsl/nw): denotes the proba-
bility of transitioning from a sedentary to an active state. It is calculated
as the reciprocal of the average sedentary bout duration, where the seden-
tary bout length is defined as the number of consecutive minutes spent in
a sedentary state (activity counts < 100 counts per minute). SATP and
ASTP measures could capture the PA fragmentation of participants.
The above PA summaries are all obtained for one day and are subsequently av-
eraged over the valid days. Although participants in NHANES were instructed
to wear the device for the full 7-day period, not all of them completed the re-
quirements. Therefore, the means of PA measurements for each participant
are calculated on the basis of his or her number of days with good quality PA
data (valid days) [19].
2.2.2 Confounding Variables
For quantifying the association between location-specific CP and PA measure-
ments, the following CP risk factors were discussed as potential confounding
13
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variables: gender, age, race/ethnicity, body mass index (BMI), education sta-
tus, current employment status, cigarette/tobacco use, alcohol consumption,
diabetes mellitus, congestive heart failure (CHF), asthma, emphysema, bron-
chitis, cancer (nonskin), myocardial infarction, stroke. The selection of the
above variables is based on previous publications.
Demographic variables in NHANES such as gender, race/ethnicity, age (years),
and the highest degree received were recorded during the home interview. In
this analysis, race/ethnicity is categorized as white, (non-Hispanic) white, (non-
Hispanic) black, Mexican-American, other Hispanic, and other. Education sta-
tus is classified as three levels including less than high school, high school
or equivalent, and college graduate or above. Participants’ height and weight
were measured and used to calculate BMI (kg/m2) during the body measure-
ment component [43]. We categorize BMI into four levels: underweight (BMI
≤ 18.5), normal (18.5 < BMI ≤ 25), overweight (25 < BMI ≤ 30), and obese (BMI
> 30).
For lifestyle condition covariates, some require additional data processing, which
includes merging information from multiple questions. For example, when cre-
ating the current employment variable, we consider the following two ques-
tions: 1) whether worked at a job or business last week, and 2) whether usually
works 35 or more hours per week. We use this information to categorize individ-
uals into full-time employed, part-time employed, and unemployed. Similarly,
current alcohol consumption is categorized into three levels as non-drinker,
moderate drinker, and heavy drinker, and the self-reported history of smoking
is grouped into never smoker, former smoker, and current smoker. More de-




For each medical condition covariate of interest, participants were asked whether
a doctor ever told them that they have that particular disease. According to
their responses, we created binary indicator variables to denote individual sta-
tus of diabetes mellitus, CHF, asthma, emphysema, bronchitis, cancer, myocar-
dial infarction, and stroke.
2.3 Statistical Analysis
2.3.1 Exploratory Analysis
First, we conduct descriptive analyses to describe the basic features of demo-
graphic and clinical characteristics for the NHANES population, stratified by
pain location and gender. Since all the covariates are binary or categorical vari-
ables, we provide the sample size of study participants in each category and the
corresponding percentage (in parentheses).
Next, in order to examine how the PA levels change by age for each pain status,
we display the average daily value of PA measures across the whole age range
for the CP groups, respectively.
In addition, we investigate and compare the daily PA level within each location-
specific CP group. We plot the average minute-specific activity counts across




We establish three groups of multiple linear regression models to examine the
association between chronic pain and objectively measured physical activity,
sequentially adjusting for sociodemographic characteristics and various med-
ical conditions that might confound the relationship. All regression models
were estimated separately for the 8 PA outcome measurements: TAC, TLAC,
CPM, ST, LIPA, MVPA, ASTP, and SATP.
Considering the complex survey design in sampling, NHANES assigns a sam-
ple weight to each participant, indicating the number of individuals in the U.S.
population who are represented by that particular participant. In this anal-
ysis, all models incorporate the participants’ 2-year full sample examination
weights, so that results are generalizable to the U.S. population. We normalize
the survey weights in the 2003-2004 wave to increase numerical stability for the
estimation procedures using the reweight accel() function from rnhanesdata
package in R [8,44]. The survey-weighted regression models are implemented
using the svyglm() function from the survey package.
To compute standard errors of survey estimates from the NHANES stratified
multistage sampling design, we created a replicate-weights survey design us-
ing the Balanced Repeated Replicates (BBR) technique. It is a resampling
method that builds a set of “balanced” pseudoreplicated datasets from the orig-
inal dataset. We apply the as.svrepdesign() function in the R package survey
and specify the type argument as “BRR”. The R code of the statistical model




First, we conduct non-stratified analyses. Study participants with CP in
each pain location of interest (upper limbs, spine, lower limbs) as well as
people with CP in at least one of the three locations were compared with
study participants with no pain. This was implemented by fitting three
models that sequentially adjust for an increasing number of potential con-
founders as follows:
• Model 1: The first model considers the marginal association between
PA and location-specific CP, where a binary indicator has been used
to denote the pain status (presence/absence) at the specific location.
The no pain group serves as the reference group.
• Model 2: The second model includes the status of location-specific
CP and, in addition, adjusts for gender (male/female), age, BMI (un-
derweight, normal, overweight, obese), race/ethnicity (White, Mexican-
American, Black, other Hispanic, other), education status (less than
high school, high school equivalent, more than high school), current
employment (unemployed, part-time employed, full-time employed),
history of smoking (current, former, never), and alcohol consumption
(non-drinker, moderate, heavy).
• Model 3: The third model includes all variables present in Model 2
and additionally adjusts for indicator variables (yes/no) of a variety of
medical conditions, including diabetes, CHF, stroke, cancer, asthma,
emphysema, bronchitis, and myocardial.
ii) Stratified Models
Next, we fit the models stratified by gender. In addition, we present re-
sults across the entire age range as well as stratified by 20-year age cat-
egories: 25-45, 45-65, and 65-85, based on the consideration that the asso-
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ciation between CP and PA measurements might not be consistent across
the entire age range.
For each pain location of interest (upper limbs, spine, lower limbs), we
fit similar three group of models. The only difference compared with the
above models is that we do not include age as a potential confounder in
Models 2 and 3 anymore:
• Model 1: The first model considers the marginal association between
PA and location-specific chronic pain, where a binary indicator has
been used to denote the pain status (presence/absence) on the specific
location. The no pain group serves as the reference group.
• Model 2: The second model includes the status of location-specific
chronic pain and, in addition, adjusts for age, BMI, race/ethnicity,
education status, current employment, history of smoking, and alco-
hol consumption.
• Model 3: The third model includes all variables present in Model 2
and additionally adjusts for diabetes, CHF, stroke, cancer, asthma,
emphysema, bronchitis, and myocardial.
All estimates of the pain indicator variable are presented as point estimates
with 95% confidence intervals (CIs). We considered type I error rates of 0.05





In this section, we provide data visualizations to summarize the population
prevalence of CP and display the characteristics of potential confounders and
PA measures within different subgroups.
3.1.1 Prevalence of Chronic Pain
Figure 3.1 displays the sample size for the entire data set and three age sub-
groups. In this figure, the above panel is for females and the one below one
is for males. Different color bars indicate pain locations: arm (violet), spine
(blue), leg (green), and any of the three body locations (yellow).
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Figure 3.1: Number of people reporting chronic pain at various body loca-
tions(arm: violet, spine: blue, leg: green, any body locations: yellow) stratified
by gender (top plot corresponds to females) and age (x-axis).
Figure 3.1 indicates that in the entire group there are 229 females and 178
males who reported CP in at least one body location (upper limbs, spine, or
lower limbs). The sex ratio is around 1 : 1 in our complete dataset (1, 263 are
females and 1, 253 males) and the percent of reporting CP for females (18.1%)
is larger than for males (14.2%), which holds even for the re-weighted preva-
lence (19.8% for females and 16.1% for males). However, the difference in the
unweighted and weighted means is smaller than what was previously reported
in the literature. The ratio of reporting CP for females is higher for all three
age groups (12.9% for females vs. 11.2% for males in the 25-45 age group, 24.9%
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vs. 18.6% in the 45-65 age group, and 16.1% vs. 13% in the 65-85 age group).
We also investigate how age is associated with the reported CP status. Study
participants between 45-65 have the largest percentage (23.1%) of reporting CP
in at least one location (arm, spine, or leg) compared to the 25-45 and 65-85 age
groups, which are 15.3% and 15.9%, respectively. This finding holds for both
females and males. Indeed, 24.9% of females and 18.6% of males aged 45-65
years old reported CP, both of which are higher than the prevalence of CP both
in the 25-45 (12.9% for females and 11.2% for males) and 65-85 (16.1% for females
and 13% for males) age groups.
Third, we inspect the sample size of different location-specific CP. For the 25-45
years old age group, chronic spinal pain is most common in both males and
females (9.8% in females and 8.6% in males). For people aged 45-65 and 65-85,
the prevalence of CP in spine and lower limbs become almost equal (In 45-65
females: 15.6% for spine and 15.8% for leg; In 45-65 males: 12.5% for spine and
11.5% for leg; In 65-85 females: 9.9% for both spine and leg; In 65-85 males: 7.7%
for both spine and leg), which are higher than the reported prevalence in the
upper limbs (12.4% in 45-65 females, 8.8% in 45-65 males, 7.5% in 65-85 females,
4.8% in 65-85 males)
3.1.2 Demographic and Clinical Characteristics
Table 3.1 provides mean and standard deviations for continuous variables
and counts and percentages for categorical variables (by rows) stratified by
sex and location of CP (by columns). The covariates considered include age,
race, sociodemographic status, life behaviors, and medical conditions. In all
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Table 3.1: Summaries of demographic and medical characteristics, organized
by location-specific CP groups, CP in any location (arm, spine, or leg) group,
and no pain group. For the binary and categorical variables, the sample size
of study participants in each category and the corresponding percentage (in
parentheses) are provided.
CP groups, nearly half of the individuals who report CP are aged 45-65. Study
participants who do not report pain are evenly distributed in the three age
categories. Among males without pain there are 35.4% aged 25-45, 31% aged
45-65, and 33.6% aged 65-85. Among females without pain there are 35.2% aged
25-45, 33.3% aged 45-65, and 31.6% aged 65-85). Moreover, for both males and
females, the proportions of white, obese, unemployed and current smoker are
substantially higher in the CP groups compared to the no pain group. For in-
stance, 71.3% males and 63.3% females with CP in any location (arm, spine, or
leg) are white, and the corresponding percentages in the no pain group are 54%
and 53.3%. Comorbidities seem to be associated to CP. For example, the preva-
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lence of asthma in males ranges from 14.5% to 18.3% across CP groups and is
6.8% in the no pain group. Similar differences can be observed for diabetes,
bronchitis, and myocardial disease. We conclude that these demographic and
medical characteristics need to be considered as potential confounders in the
association between objectively measured PA and CP.
3.1.3 PA Characteristics
i) PA measures across age
Figure 3.2: Average daily value of eight PA measures as functions of age (x-
axis) stratified by gender (male: top panels) and pain locations (colors of differ-
ent lines). The y-axis denotes the value of each PA measure.
Figure 3.2 displays the average daily value of eight PA measures as func-
tions of age. The x-axes in all subplots span the entire age range consid-
ered in this analysis, 25-85 years old. Subplots are stratified by sex (male:
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top panels) and pain locations (colors of different lines). Curves are not
adjusted for any other covariates other than sex and CP location. Figure
3.2 indicates that most PA measures for males have a non-linear rela-
tionship with age within each CP group. Consider, for example, all four
curves of the CPM variable for males (first row, third column) increase
with age until 40-45 years of age and then start declining for the rest of
the age span. The curve corresponding to the no pain group (gray) is
always above the other three curves that correspond to the various CP
groups (purple, blue, and green). Such discrepancy is largest among the
25 to 45 year old group, though some large differences can be observed for
the 65 to 85 year old group.
However, for females, we observe different patterns. Note that for CPM
measurements (second row, third column): (i) the curve for the no pain
group and the three curves of CP groups are closer over the age range; (ii)
curves are linear and decline with age; (iii) the average CPM (counts er
minute) curve for CP (chronic pain) in the arm is higher than the CPM
curve for the no pain group.
Other PA outcomes, including TAC, TLAC, LIPA, and MVPA, have sim-
ilar decreasing patterns, while ST and ASTP increase with age. This is
expected, as ST is a measure of time spend sedentary and ASTP is a mea-
sure of the probability of transitioning from active to sedentary during
the day. This exploratory analysis provides a general description of how
various PA measurements change with age for males and females.
ii) Minute-level activity counts during the day
Figure 3.3 provides the average daily pattern of minute-level PA for the
entire age group for males (left) and females (right) for different pain loca-
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Figure 3.3: Average daily pattern of minute-level PA for the entire age group
for males (left) and females (right) for different pain locations (no pain: gray;
arm pain: violet; spinal pain: blue; leg pain: green). The x-axis is the time from
0 AM to 0 AM. The y-axis is the average activity count at a particular minute
of the day.
tions (no pain: gray; arm pain: violet; spinal pain: blue; leg pain: green).
Both males and females who do not report pain (gray curve) have higher
activity counts than the corresponding groups that reported CP in arm,
spine or leg. The only exception is for females who reported chronic pain
in their arms, where differences are not that clear. In general the differ-
ences between the average curves for males are much more pronounced
than for females.
Figure 3.4 provides additional insight into the effect of age on the av-
erage daily activity counts. As panels are compared from left to right
(younger to older), the average activity counts decreases for both males
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Figure 3.4: Average daily pattern of minute-level PA group for males (top pan-
els) and females (bottom panels) for the age groups 25-45 (left), 45-65 (middle),
and 65-85 (right). Different pain locations are indicated by the color of the lines
(no pain: gray; arm pain: violet; spinal pain: blue; leg pain: green). The x-axis
is the time from 0 AM to 0 AM. The y-axis is the average activity count at a
particular minute of the day.
and females across pain groups. The largest differences between PA in-
tensity profiles can be observed for females aged 45-65 and males aged
25-45 and 65-85. In the age group 25-45 the average PA level for male
and female study participants with chronic arm pain is higher than for
chronic spinal or leg pain. This phenomenon is not observed in other age
groups. These visualizations of the minute-level PA data suggest poten-
tial relationships between location-specific CP and PA.
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3.2 Non-stratified Models for Association
between PA and Pain Status
Table 3.2: Associations of PA and location-specific chronic pain for the whole
age group. Each cell shows the coefficient estimates, 95% CIs, and correspond-
ing p values of Models 1, 2, and 3. The p-values ≤ 0.05 and p-values ≤ 0.01 are
marked as * and **. Model 1: marginal model; Model 2: adjusted for gender,
age, BMI, race, education status, current employment, history of smoking, and
alcohol consumption; Model 3: adjusted for gender, age, BMI, race, education
status, current employment, history of smoking, and alcohol consumption, dia-
betes, CHF, stroke, cancer, asthma, emphysema, bronchitis, and myocardial.
Table 3.2 provides the results of the non-stratified survey-weighted regression
models in the 25-85 years old age group (entire group). For the association
between each PA outcome and pain indicator (CP in upper limbs, spine, lower
limbs, or at least one of the three locations), we provide the corresponding
coefficient estimates, 95% CIs, and p-values of Models 1, 2, and 3. We use * to
denote a p-value ≤ 0.05 and ** to denote a p-value ≤ 0.01.
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First, we provide results for Model 1, which includes only the pain indicator in
the regression model. We provide a discussion of results by for measures of PA
volume first (TAC, TLAC, CPM, ST, LIPA, MVPA) and then for measures of PA
fragmentation (SATP and ASTP).
i) Measures of PA volume
For people with CP in arm, spine, leg or any location, they all tend to have
significantly lower levels of volume of total/average activity, including
TAC (βarm = −38852.9, parm = 0.005; βspine = −51326, pspine < 0.001; βleg =
−52056.8, pleg < 0.001; βanywhere = −44505, panywhere < 0.001), TLAC(βarm =
−191.4, parm = 0.012; βspine = −230.9, pspine < 0.001; βleg = −246.8, pleg < 0.001;
βanywhere = −198.5, panywhere < 0.001); and CPM (βarm = −44.5, parm =
0.004; βspine = −56.8, pspine < 0.001; βleg = −55.9, pleg < 0.001; βanywhere =
−50.2, panywhere < 0.001). Furthermore, they also have lower light (LIPA:
βspine = −23.7, pspine < 0.001; βleg = −22.7, pleg = 0.003; βanywhere = −18.2,
panywhere = 0.002) and moderate and vigorous PA (MVPA: βarm = −6.9,
parm < 0.001; βspine = −8.5, pspine < 0.001; βleg = −9.2, pleg < 0.001; βanywhere =
−7.6, panywhere < 0.001), as well as higher sedentary time (ST: βarm =
24.1, parm = 0.027; βspine = 32.2, pspine < 0.001; βleg = 31.9, pleg < 0.001;
βanywhere = 25.9, panywhere < 0.001). The only exception is LIPA for study
participants with arm pain.
ii) Measures of PA fragmentation
Compared with people with no pain, people within the location-specific CP
groups (arm, spine, and leg) and within the CP in any location group have
significantly higher ASTP (βarm = 0.019, parm = 0.02; βspine = 0.02, pspine =
0.003; βleg = 0.017, pleg = 0.009; βanywhere = 0.017, panywhere = 0.007) and
lower SATP (βspine = −0.004, pspine = 0.034; βleg = −0.006, pleg < 0.001;
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βanywhere = −0.003, panywhere = 0.008). The only exception is SATP in people
with arm pain.
Next, we consider the effects of potential confounders and establish adjusted
models (Models 2 and 3):
i) Measures of PA volume
For participants with chronic spinal pain, in both Models 2 and 3, their
pain status are significantly associated with TAC (Model 2 : β = −26224.8,
p = 0.002; Model 3 : β = −22042.7, p = 0.012), TLAC (Model 2 : β =
−119, p = 0.012; Model 3 : β = −84.4, p = 0.049), CPM (Model 2 : β =
−30.5, p = 0.004; Model 3 : β = −25.9, p = 0.013), ST (Model 2 : β =
17.2, p = 0.013; Model 3 : β = 12.1, p = 0.047), MVPA (Model 2 : β =
−4.6, p = 0.001; Model 3 : β = −4.3, p = 0.003). In addition, in Model 2,
CP in leg is significantly related to TAC (β = −16707.4, p = 0.042) and
MVPA (β = −3.7, p = 0.036), and CP in any location is related to MVPA
(β = −3.3, p = 0.035).
ii) Measures of PA fragmentation
In adjusted analyses, there are no significant differences between the ei-
ther CP group and the no pain group.
In summary, in the entire group (25-85 years old), study participants with CP in
any location have less PA in the marginal models. However, the statistical sig-




3.3 Stratified Models for Association be-
tween PA and Pain Status
Tables 3.3, 3.4, 3.5 and 3.6 provide results similar with Table 3.2. However,
they display the results of stratified models in different age groups (whole age
range, 25-45 years old, 45-65 years old, and 65-85 years old) separately. The
outputs within each table are organized by pain locations (upper limbs, spine,
and lower limbs) and gender (male/female). In this section, we will describe
the association results by age group, starting with the entire group and then
from the youngest to the oldest groups.
3.3.1 Associations in the entire age group
Table 3.3 displays the estimated associations between the 8 daily PA sum-
maries and location-specific CP for the 25-85 years old age group (entire group).
We first investigate the results obtained from the marginal models (Model 1) to
discuss the PA volume (TAC, TLAC, CPM, ST, LIPA, MVPA) and the measures
of PA fragmentation (SATP and ASTP).
i) Measures of PA volume
In unadjusted analyses, people with either spinal or leg CP, both males
and females tend to have significantly lower levels of TAC (males : βspine =
−57405.5, pspine < 0.001; βleg = −61876.7, pleg < 0.001; females : βspine =
−39534.5, pspine = 0.001; βleg = −33563.2, pleg = 0.014), TLAC (males :
βspine = −270.3, pspine < 0.001; βleg = −322.7, pleg < 0.001; females : βspine =
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Table 3.3: Associations of PA and location-specific chronic pain for the whole
age group. Each cell shows the coefficient estimates, 95% CIs, and correspond-
ing p-values for Models 1, 2, and 3. The p-values ≤ 0.05 and p-values ≤ 0.01 are
marked as * and **, respectively. Model 1: marginal model; Model 2: adjusted
for age, BMI, race, education status, current employment, history of smoking,
and alcohol consumption; Model 3: additional adjustments for diabetes, CHF,
stroke, cancer, asthma, emphysema, bronchitis, and myocardial disease.
−187.2, pspine = 0.011; βleg = −176.6, pleg = 0.021), CPM (males : βspine =
−66.3, pspine < 0.001; βleg = −69.4, pleg < 0.001; females : βspine = −41.6, pspine =
0.001; βleg = −34.1, pleg = 0.031), when comparing with those without pain.
In addition, males with CP in spine or leg have lower LIPA (βspine =
−28.9, pspine = 0.01; βleg = −35.5, pleg = 0.001), lower MVPA (βspine =
−9.2, pspine < 0.001; βleg = −9.3, pleg = 0.009), and higher ST (βspine =
38, pspine = 0.002; βleg = 44.8, pleg < 0.001). Females with spinal or leg pain
have lower MVPA (βspine = −6.7, pspine < 0.001; βleg = −6.8, pleg < 0.001),
while females with spinal pain have higher ST (β = 25.4, p = 0.012).
Males with chronic arm pain have lower TAC (β = −44208.9, p = 0.006),
TLAC (β = −195.1, p = 0.025), CPM (β = −56.4, p = 0.003), and MVPA
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(β = −7.4, p = 0.021) when compared to the no-pain group. For females,
only MVPA is significantly different (β = −5.2, p = 0.012). In general, the
estimated differences in PA measurements between pain groups tend to
be lower in females compared to males.
ii) Measures of PA fragmentation
In unadjusted analyses, ASTP tends to be significantly higher for males
with CP at any body location (βarm = 0.023, parm = 0.022; βspine = 0.021, pspine =
0.035; βleg = 0.027, pleg < 0.001) and females with spinal CP (β = 0.017, p =
0.036). SATP tends to be lower for males with leg or spinal CP (βspine =
−0.004, pspine = 0.031; βleg = −0.007, pleg = 0.011) and females with arm or
leg pain (βarm = −0.006, parm = 0.043; βleg = −0.006, pleg = 0.003).
Next, we consider the effects of potential confounders and summarize the re-
sults in adjusted models (Models 2 and 3):
i) Measures of PA volume
In adjusted models, the females in the spinal CP have significantly lower
levels of TAC (Model 2 : β = −23339.7, p = 0.002; Model 3 : β = −19748, p =
0.033) and MVPA (Model 2 : β = −4.3, p = 0.002; Model 3 : β = −4.2, p =
0.011) in Models 2 and 3, and lower CPM (β = −25.1, p = 0.006) in Model 2.
For males with spinal pain, the only significant difference was observed
for MVPA (β = −5.2, p = 0.024) in Model 2. In the leg CP group males tend
to have significantly lower CPM (β = −26.3, p = 0.015) and females have
lower MVPA (β = −4, p < 0.001) compared to the no-pain group. After
adjusting for confounders, in the arm CP group there are no PA outcomes
that are significantly associated with pain status.
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ii) Measures of PA fragmentation
After adjusting for confounders, there are no significant differences for
either sex when comparing CP groups with the no pain group.
Results suggest that marginally, in the 25-85 years old age sample, individuals
with any type of CP engage in less physical activity in both males and females,
and have increased activity fragmentation. Differences between CP groups
are less pronounced in females compared to males, and the differences appear
to vary based on the CP location. For many locations, except those discussed
above, the statistical significance of the association disappears when adjusting
for potential confounders. This could be due to the small sample sizes used
once data are stratified by sex and CP location.
3.3.2 Associations in the 25-45 years old age group
Table 3.4 provides results similar with Table 3.3, but focused on the 25-45
age group instead of the entire group. We first investigate the results obtained
from the marginal models (Model 1):
i) Measures of PA volume
For males having spinal and leg CP, have significantly lower TAC (βspine =
−86911.2, pspine < 0.001; βleg = −87056.1, pleg = 0.025), TLAC (βspine =
−357.3, pspine < 0.001; βleg = −530.1, pleg = 0.004), CPM (βspine = −115.1,
pspine < 0.001; βleg = −112.6, pleg = 0.006), LIPA (βspine = −39.8, pspine < 0.001;
βleg = −74.1, pleg = 0.002), and higher ST (βspine = 53.9, pspine < 0.001; βleg =
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Table 3.4: Associations of PA and location-specific chronic pain for the 25-45
age group. Each cell shows the coefficient estimates, 95% CIs, and correspond-
ing p values of Models 1, 2, and 3. The p-values ≤ 0.05 and p-values ≤ 0.01 are
marked as * and **.
83.4, pleg = 0.002), which is consistent with lower levels of volume of ac-
tivity compared to study participants who did not report CP. In addition,
MVPA is significantly lower for males with spinal CP compared to the no
CP group (β = −14.1, p = 0.001), though not for those with leg CP.
ii) Measures of PA fragmentation
Compared with the no CP group, ASTP is significantly higher for males
having chronic spinal or leg pain (βspine = 0.035, pspine = 0.009; βleg =
0.047, pleg = 0.004), but it is lower for females having chronic arm or leg
pain (βarm = −0.043, parm = 0.019; βleg = −0.032, pleg = 0.008). For SATP,
only females with leg CP have a significantly lower value compared to the
no CP group (β = −0.009, p = 0.008).
Next, we consider the effects of potential confounders and establish adjusted
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models (Models 2 and 3) for the 25-45 age group:
i) Measures of PA volume
For males with CP in spine, in both adjusted Models 2 and 3, the pain sta-
tus is significantly associated with all measures of PA volume including
TAC (Model 2 : β = −62041.4, p < 0.001; Model 3 : β = −56516.7, p < 0.001),
TLAC (Model 2 : β = −223, p < 0.001; Model 3 : β = −184.3, p = 0.012),
CPM (Model 2 : β = −87.7, p < 0.001; Model 3 : β = −80.9, p < 0.001),
ST (Model 2 : β = 35.4, p = 0.001; Model 3 : β = 30.6, p = 0.006), LIPA
(Model 2 : β = −24.8, p = 0.027), and MVPA (Model 2 : β = −10.6, p < 0.001;
Model 3 : β = −9.3, p < 0.001). The only exception was LIPA in Model
3. For males with CP in leg, the CP indicator is significantly associated
with ST (Model 2 : β = 53.7, p = 0.013; Model 3 : β = 51.5, p < 0.001) and
LIPA (Model 2 : β = −50.2, p = 0.013; Model 3 : β = −48.6, p = 0.003)
in both Model 2 and Model 3, and it is significantly associated with TAC
(β = −45797, p = 0.018), TLAC (β = −308.6, p = 0.001), and CPM (β =
−65.3, p = 0.001) only in Model 3.
We also observe some counter-intuitive results for females with chronic
arm pain. Compared to females who did not report pain, they tend to
have statistically significant and higher TAC (β = 44560.1, p = 0.001),
TLAC (β = 221.8, p = 0.004), CPM (β = 50.9, p = 0.003), LIPA (β =
50.6, p < 0.001), and lower ST (β = −51.8, p < 0.001) in Model 3. This
finding is consistent with Figure 2.
ii) Measures of PA fragmentation
In both Models 2 and 3, ASTP is significantly lower for females with CP
in arm or leg (Model 2 : βarm = −0.05, parm = 0.023; βleg = −0.034, pleg =
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0.003; Model 3 : βarm = −0.05, parm < 0.001; βleg = −0.029, pleg < 0.001), and
it is higher for males with CP in leg (Model 2 : β = 0.028, p = 0.017; Model 3 :
β = 0.026, p < 0.001). In the spinal pain group, ASTP is lower for females
but higher for males in Model 3 compared to the corresponding no pain
group (males : β = 0.02, p = 0.005; females : β = −0.013, p < 0.001).
In addition, in Model 3, males with CP in arm have higher SATP (β =
0.009, p < 0.001), while females with CP in leg have lower SATP (β =
−0.006, p = 0.018) compared to the corresponding no pain group.
In summary, among the group 25-45 age group, males with either spinal or leg
CP are less physically active even after adjusting for confounding. In addition,
females with arm CP tend to have higher levels of total PA as well as light,
moderate, and vigorous intensity PA, even after adjusting for demographic and
medical covariates.
3.3.3 Associations in the 45-65 years old age group
Table 3.5 provides results similar with Tables 3.3 and 3.4, but focused on the
45-65 age group. We first investigate the results obtained from the marginal
models (Model 1):
i) Measures of PA volume
In unadjusted analyses, females with any type of chronic pain (arm, spine,
or leg) engage in significantly less physical activity as indicated by their
lower TAC (βarm = −51933.5, parm = 0.004; βspine = −69354.6, pspine < 0.001;
βleg = −47579, pleg = 0.001), TLAC (βarm = −358.5, parm = 0.004; βspine =
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Table 3.5: Associations of PA and location-specific chronic pain for the 45-65
age group. Each cell shows the coefficient estimates, 95% CIs, and correspond-
ing p values of Models 1, 2, and 3. The p-values ≤ 0.05 and p-values ≤ 0.01 are
marked as * and **.
−328.6, pspine = 0.018; βleg = −305.8, pleg = 0.002), CPM (βarm = −52.8, parm =
0.006; βspine = −76.2, pspine < 0.001; βleg = −51.5, pleg = 0.002), LIPA (βarm =
−48.1, parm = 0.003; βspine = −41, pspine = 0.034; βleg = −36.7, pleg = 0.021),
MVPA (βarm = −7.3, parm < 0.001; βspine = −10.1, pspine < 0.001; βleg =
−7.7, pleg < 0.001), and higher ST (βarm = 55.4, parm = 0.001; βspine =
51.2, pspine = 0.008; βleg = 44.4, pleg = 0.006). For males, only the ones
with CP in leg have lower values of TAC (β = −39401.3, p = 0.008), CPM
(β = −35.3, p = 0.004), and MVPA (β = −7, p = 0.024).
ii) Measures of PA fragmentation
In unadjusted analyses, ASTP is significantly higher for females with
with any type of CP (βarm = 0.043, parm = 0.004; βspine = 0.046, pspine =
0.002; βleg = 0.033, pleg = 0.025), and SATP is lower for those with CP in
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arm or leg (βarm = −0.008, parm = 0.023; βleg = −0.007, pleg = 0.013). How-
ever, there are no differences in either ASTP or SATP for males.
Second, we focus on the the adjusted models (Models 2 and 3):
i) Measures of PA volume
After adjusting for confounders, there is no significant difference between
CP and no pain groups in males. For females, measures of PA volume
(TAC, TLAC, CPM) are significantly associated with pain status in Model
2 (TAC: βarm = −31401.5, parm = 0.033; βspine = −57894.4, pspine < 0.001; βleg =
−33182.9, pleg = 0.013; TLAC: βarm = −233.4, parm = 0.032; βleg = −211.8, pleg =
0.041; CPM: βspine = −66.8, pspine < 0.001). Some exceptions are CPM for
the arm and leg pain group and TLAC for the spinal pain group. In the
fully adjusted Model 3, only TAC (β = −50793.2, p = 0.002) and CPM
(β = −60.2, p = 0.006) are significantly associated with spinal pain, and
TLAC (β = −131.4, p = 0.034) is associated with leg pain.
For PA volume estimators for time spent in specific activity intensity (ST,
LIPA, MVPA), the significance levels appear to differ by the locations of
CP. In adjusted Models 2 and 3, ST (Model 2 : β = 38.7, p = 0.017; Model 3 :
β = 27.8, p = 0.014), LIPA (Model 2 : β = −33.6, p = 0.032; Model 3 : β =
−23, p = 0.031), and MVPA (Model 2 : β = −5.1, p = 0.011; Model 3 : β =
−4.8, p = 0.048) are all associated with arm pain, and MVPA is also asso-
ciated with spinal and leg pain (Model 2 : βspine = −9, pspine = 0.002; βleg =
−6.2, pleg = 0.001; Model 3 : βspine = −9.1, pspine = 0.004; βleg = −5.9, pleg =
0.008).
ii) Measures of PA fragmentation
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In adjusted models, only ASTP in Model 2 is significantly higher for fe-
males with CP in arm or spine (βarm = 0.035, parm = 0.044; βspine = 0.043,
pspine = 0.017).
In summary, for the 45-65 years old age group, the estimated differences for
measurements of both volume and fragmentation tend to be stronger in fe-
males than males. Females with any type of chronic pain engage in less phys-
ical activity, and the statistical significance of some measures of association
hold even after adjusting for confounders.
3.3.4 Associations in the 65-85 years old age group
Table 3.6: Associations of PA and location-specific chronic pain for the 65-85
age group. Each cell shows the coefficient estimates, 95% CIs, and correspond-
ing p values of Models 1, 2, and 3. The p-values ≤ 0.05 and p-values ≤ 0.01 are
marked as * and **.
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Table 3.6 provides results similar with Tables 3.3, 3.4, and 3.5, but focused on
the 65-85 age group. We first investigate the results obtained from the marginal
models (Model 1):
i) Measures of PA volume
In unadjusted analyses, for females there are no significant differences
in PA levels between the CP groups and no pain group. For males with
CP, irrespective to pain location, they all tend to have lower levels of TAC
(βarm = −45078.2, parm = 0.001; βspine = −50490.5, pspine < 0.001; βleg =
−45985.2, pleg = 0.001), CPM (βarm = −49.7, parm = 0.004; βspine = −52.7,
pspine < 0.001; βleg = −43.7, pleg = 0.036), and MVPA (βarm = −6.2, parm =
0.003; βspine = −7.6, pspine < 0.001; βleg = −7.6, pleg < 0.001). In addition,
males with spinal pain have lower TLAC (β = −246.8, p = 0.029) and
higher ST (β = 33.4, p = 0.039) .
ii) Measures of PA fragmentation
In unadjusted analyses, only males with CP in spine tend to have higher
ASTP (β = 0.031, p = 0.045).
Further, the adjusted models (Models 2 and 3) suggest that:
i) Measures of PA volume
In adjusted models, the differences in PA outcomes comparing individuals
with and without pain remains significant for males. In Models 2 and
3, both spinal and leg pain indicators are significantly associated with
TAC (Model 2 : βspine = −51780.5, pspine < 0.001; βleg = −42618.1, pleg =
0.001; Model 3 : βspine = −39404.9, pspine < 0.001; βleg = −42463.8, pleg =
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0.001), CPM (Model 2 : βspine = −54.5, pspine = 0.001; βleg = −38.5, pleg =
0.04; Model 3 : βspine = −44.1, pspine < 0.001; βleg = −38.9, pleg = 0.032),
and MVPA (Model 2 : βspine = −7.7, pspine < 0.001; βleg = −6.6, pleg < 0.001;
Model 3 : βspine = −5.6, pspine < 0.001; βleg = −6.3, pleg < 0.001), and leg
pain is significantly associated with TLAC (Model 2 : β = −208.5, p =
0.044; Model 3 : β = −241, p = 0.022). Arm pain is associated with TAC
(β = −34555.7, p = 0.05) in Model 2 but not in Model 3.
ii) Measures of PA fragmentation
In fully adjusted models (Model 3), ASTP is significantly higher for males
with any type ofCP (βarm = 0.033, parm = 0.047; βspine = 0.034, pspine =
0.017; βleg = 0.039, pleg = 0.038). In models adjusted only for demographic
variables (Model 2), ASTP was only higher for males with CP in spine
(β = 0.039, p = 0.022).
In summary, among the 65-85 years old males, participants with CP have sig-
nificantly lower PA levels than those with no pain. In general, the differences





We have assessed the associations between PA measures and CP in different
body locations, and have shown that the magnitude of the associations may
vary by gender and age strata. To the best of our knowledge, this is the first
population-based research studying the association between location-specific
CP and objective measures of PA. Our results provide evidence indicating that:
(i) individuals with CP tend to engage in less PA compared to the ones with
no pain; and (ii) these differences are more pronounced in males than females
especially in the 25-45 and 65-85 age groups. The present study shows that 25-45
and 65-85 years old males with CP in spine or lower limbs, and 45-65 years old
females with CP in upper limbs, spine, or lower limbs tend to have lower values
of TAC, a measure that is strongly correlated with maximum intensity activity.
Furthermore, 45-65 year old females with any type of CP and young males
with CP in spine have higher ST, lower LIPA and MVPA compared to those
without pain. They also have higher ASTP, a measure of PA fragmentation.
Finally, for 65-85 year old males, spinal and leg CP is significantly associated
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with MVPA but not LIPA. Although adjusting for relevant covariates typically
reduces the magnitude of estimated associations between CP and PA outcomes,
most differences discussed above remain statistically significant (as shown in
Table 3.3, Models 2 and 3).
These findings add to the current understanding of CP at various body loca-
tions, which could potentially be used to gain additional insights into CP pain
management. Previous evidence indicates that regular PA may be beneficial
for treating and even preventing chronic pain [16, 45, 46]. Therefore, wear-
able technology could be used to continuously monitor individuals’ PA volume,
intensity, and fragmentation. Coupled with information about pain intensity
and timing, this information could potentially be used to further explore the
association and causal direction of the association between PA and pain. PA
interventions could potentially reduce CP and improve pain at the individual
level and help improve CP management systems [19,20].
Our study extends previous investigations of the association of CP with PA
measures and has several strengths. First, we make use of the data collected
by the NHANES, which is a large, US representative survey that contains de-
tailed information about CP, PA, and potential confounders. Second, NHANES
provides information about the specific body regions that are experiencing CP.
We have used this information to explore the potential of differential associ-
ations between CP and PA by location of CP. Third, our study used objective,
accelerometer-assessed PA data, which is less prone to bias and measurement
error compared to self-reported PA. Moreover, we have considered several PA
measurement summaries of volume (TAC, TLAC, SPM), intensity duration (ST,
LIPA, MVPA), and fragmentation (SATP and ASTP). The normality of the
distribution for each PA measure distribution has been checked. Fourth, we
43
CHAPTER 4. DISCUSSION
have conducted age-stratified analyses, as the prevalence of CP varies with age
groups and associations between PA and CP may vary non-linearly with age.
Fifth, we have conducted both unadjusted and adjusted analysis by taking into
account potential demographic and medical history confounders.
Our study has several weakness. First, the pain symptoms are self-reported by
participants instead of being examined by clinical diagnosis. This may affect
the definition of CP as the duration of pain may not be accurately estimated.
Some individuals who were classified as part of the pain group in NHANES
may not meet the clinical criterion for CP, while some study participants who
met the clinical criteria might have been missed in NHANES due to self report.
Second, our study is designed to quantify the association between CP and PA,
but was not designed to study the causal pathways. Third, NHANES does not
contain information about pain intensity, which did not allow us to investigate
the association between objective and self-reported pain intensity [19]. Fourth,
NHANES did not use the “Miscellaneous Pain” questionnaire after the 2003-
2004 cycle, which made it impossible to use the 2005-2006 NHANES PA data in
this study. Fifth, the generalization of current results to the 2021 US population
given that data are now 17 to 18 years old. Sixth, the sample sizes in the three
CP groups are relatively small compared with the no pain group, which could
have effects on the stability and reproducibility of results.
In conclusion, our study supports and enriches past publications assessing the
relationship between CP and PA. Using the best available public data for the
U.S. population, we conduct a study of association between location-specific CP
and objective PA summary measurements. The results suggest that the as-
sociation of PA measures with CP varies by the patients’ CP location, gender,
and age category. Our findings further emphasize the importance of wearable
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technology in health-related research. More research is needed to explore the




R Code for Model Fitting
A.1 Non-stratified Models
The R code of the non-stratified model fitting has been provided as the follow-
ing:
> # Apply the survey weights in the 2003-2004 wave,
using the normalized 2-year full sample examination weights
> # Use the complete dataset
> data_svy <- svydesign(id = ˜SDMVPSU,
strata = ˜SDMVSTRA,
weights = ˜wtmec2yr_unadj_norm,
data = data, nest = TRUE)
> # Creates a replicate-weights survey design object,
using the balanced repeated replicates (BBR) technique
> data_brr <- as.svrepdesign(data_svy, type = "BRR")
> # Model 1: Marginal model
> model1 = svyglm(PA outcome ˜ CP indicator, design = data_brr)
> # Model 2: Adjusted for demographic confounders
> model2 = svyglm(PA outcome ˜ CP indicator + Gender +
Age + BMI + Race + Education + Employment +
Smoking + Drinking, design = data_brr)
> # Model 3: Adjusted for demographic and medical
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condition confounders
> model3 = svyglm(PA outcome ˜ CP indicator + Gender +
Age + BMI + Race + Education + Employment +
Smoking + Drinking + Diabetes + CHF +
Stroke + Cancer + Asthma + Emphysema +
Bronchitis + Myocardial, design = data_brr)
A.2 Stratified Models
The R code of the stratified model fitting has been provided as the following:
> # Apply the survey weights in the 2003-2004 wave,
using the normalized 2-year full sample examination weights
> # Use the data with samples in specific gender and age group
of which association we are examining
> data_svy <- svydesign(id = ˜SDMVPSU,
strata = ˜SDMVSTRA,
weights = ˜wtmec2yr_unadj_norm,
data = data, nest = TRUE)
> # Creates a replicate-weights survey design object,
using the balanced repeated replicates (BBR) technique
> data_brr <- as.svrepdesign(data_svy, type = "BRR")
> # Model 1: Marginal model
> model1 = svyglm(PA outcome ˜ CP indicator, design = data_brr)
> # Model 2: Adjusted for demographic confounders
> model2 = svyglm(PA outcome ˜ CP indicator + Age +
BMI + Race + Education + Employment +
Smoking + Drinking, design = data_brr)
> # Model 3: Adjusted for demographic and medical
condition confounders
> model3 = svyglm(PA outcome ˜ CP indicator + Age +
BMI + Race + Education + Employment +
Smoking + Drinking + Diabetes + CHF +
Stroke + Cancer + Asthma + Emphysema +
Bronchitis + Myocardial, design = data_brr)
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